Test Price
2,800 AEDโ Home Collection Available
LMNA Gene Test for Emery-Dreifuss Muscular Dystrophy Type 2 (NGS)
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity โ ISO-accredited NGS facility with full gene coverage.
- Premium Logistics โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM โ 11 PM daily).
- Clinical Guidance โ Telephonic post-test interpretation session included.
- Insurance โ Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This LMNA gene test utilizes Next Generation Sequencing (NGS) to detect pathogenic variants causing Emery-Dreifuss Muscular Dystrophy type 2, a disorder affecting skeletal muscles, joints, and cardiac function. The test provides comprehensive analysis of all coding regions and intron-exon boundaries, with deletion/duplication detection (CNV analysis).
| Feature | Our LMNA NGS Test | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity; full gene coverage | โฅ99% sensitivity; limited to known hotspots |
| Methodology | NGS (Illumina) with deletion/duplication analysis | Sanger sequencing; no CNV detection |
| Turnaround Time | 3โ4 weeks | 4โ6 weeks |
Physician Insight & Safety Protocols
โGenetic testing for Emery-Dreifuss muscular dystrophy is a sensitive step. I understand the anxiety it can bring. This NGS panel provides valuable information, but please remember that results must be interpreted alongside your clinical picture and family history. I am here to guide you through this journey.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Medication & Treatment Continuity
โ ๏ธ Do not discontinue any prescribed cardiac or neuromuscular medication without consulting your physician. This test does not replace ongoing care.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals with acute febrile illness; inability to provide informed consent (minors require parental consent); heavy uncontrolled bleeding.
- Red Flags: Seek immediate emergency care if you experience: sudden chest pain, palpitations, syncope, rapidly progressive muscle weakness, or difficulty swallowing/breathing. This test does not replace emergency cardiac evaluation.
Patient FAQ & Clinical Guidance
1. What does the LMNA gene test for Emery-Dreifuss muscular dystrophy type 2 involve?
This advanced DNA test analyzes all coding regions of the LMNA gene using Next Generation Sequencing (NGS) to identify disease-causing mutations. The test requires a simple blood sample and results are available in 3โ4 weeks.
2. How is the sample collected and when will I receive my results?
A 3 mL blood sample or one drop of blood on an FTA card is collected. Our team offers a paid VIP home collection service with ISO-certified cold-chain logistics. A DHA-licensed phlebotomist will arrive within your chosen time window (8 AM โ 11 PM). After the specimen reaches the lab, NGS sequencing and bioinformatic analysis are performed. You will receive a secure electronic report and a scheduled telephonic consultation to discuss findings.
3. Is this test suitable for children and what are the UAE legal requirements?
Yes, this test is suitable for minors under strict UAE legal frameworks. Testing of individuals under 18 requires informed parental consent and a pre-test genetic counseling session to explain potential outcomes. Our clinic provides a certified genetic counselor to ensure full ethical compliance. Analysis can be performed on blood or a painless FTA card finger-prick sample to minimize distress for the child.
UAE Regulatory & Data Privacy Adherence
All genetic data is handled in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability (patient safety and consent standards)
Your information is encrypted, access-controlled, and processed solely for diagnostic purposes. For billing or scheduling, contact us via WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | LMNA Gene Test for Emery-Dreifuss Muscular Dystrophy Type 2 (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole blood (3 mL) or FTA card (dried blood spot) |
| Methodology Used | Next Generation Sequencing (Illumina) with deletion/duplication analysis (CNV) |
| ICD-10-CM Code | G71.09, Z15.89, Z82.79 |
| LOINC Code | 94487-8 |
| DHA Facility License & Laboratory Address | License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians